This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Epigenetic regulation of CD44in Hodgkin and non-Hodgkin lymphoma
BMC Cancer Open Access 29 September 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Matsuo Y, Drexler HG . Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. Leuk Res 2003; 27: 935–945.
Matsuo Y, Drexler HG, Harashima A, Okochi A, Shimizu N, Orita K . Transcription factor expression in cell lines derived from natural killer-cell and natural-killer T-cell leukemia-lymphoma. Hum Cell 2004; 17: 85–92.
Nygren AOH, Ameziane N, Duarte HMB, Vijzelaar RNCP, Waisfisz Q, Hess CJ et al. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005; 33: e128.
Esteller M . Epigenetics in cancer. N Engl J Med 2008; 358: 1148–1159.
Costello JF, Frühwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000; 25: 132–138.
Esteller M, Corn PG, Baylin SB, Herman JG . A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225–3229.
Esteller M . Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. Clin Immunol 2003; 109: 80–88.
Rahmatpanah FB, Carstens S, Guo J, Sjahputera O, Taylor KH, Duft D et al. Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior. Leukemia 2006; 10: 1855–1862.
Shi H, Guo J, Duff DJ, Rahmatpanah FB, Chitima-Matsiga R, Al-Kuhlani M et al. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis 2007; 28: 60–70.
Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A . Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ interferon-induced cell death. Genes Dev 1995; 9: 15–30.
Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T et al. DAP-Kinase participates in TNF- and RAS-induced apoptosis and its function requires the death domain. J Cell Biol 1999; 146: 141–148.
Drexler HG . Guide to Leukemia-Lymphoma Cell Lines. Braunschweig, 2005.
Nakatsuka S, Takakuwa T, Tomita Y, Hoshida Y, Nishiu M, Yamaguchi M et al. Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)/T-cell malignancies. Cancer Sci 2003; 94: 87–91.
Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A . Lack of CpG Island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol 2005; 23: 7043–7049.
Cross SH, Bird AP . CpG islands and genes. Curr Opin Genet Dev 1995; 5: 309–314.
Esteller M . CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21: 5427–5440.
Puto LA, Reed JC . Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev 2008; 22: 998–1010.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Röhrs, S., Romani, J., Zaborski, M. et al. Hypermethylation of Death-Associated Protein Kinase 1 differentiates natural killer cell lines from cell lines derived from T-acute lymphoblastic leukemia. Leukemia 23, 1174–1176 (2009). https://doi.org/10.1038/leu.2009.5
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2009.5
This article is cited by
-
Epigenetic regulation of CD44in Hodgkin and non-Hodgkin lymphoma
BMC Cancer (2010)